A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Jenny C. Chang(Universität Hamburg), Melissa D. Landis(Baylor College of Medicine), Carolina Gutiérrez(Baylor College of Medicine), Alejandro Contreras(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Lisa Wiechmann(The University of Texas MD Anderson Cancer Center), Michael T. Lewis(Baylor College of Medicine), Sufeng Mao(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Suzanne A.W. Fuqua(Baylor College of Medicine), Helen Wong(Baylor College of Medicine), Mario Giuliano(Regione Campania), Charles M. Perou(University of North Carolina at Chapel Hill), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Chad A. Shaw(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Edward S. Chen(American Thoracic Society), Anna Tsimelzon(Pancreatic Cancer Action Network), Pavel Zuloaga(The University of Texas MD Anderson Cancer Center), Anne C. Pavlick(Baylor College of Medicine), Ivana Petrović(University of Basel), Aleix Prat(Hospital Clínic de Barcelona), Xiaomei Zhang(Yangzhou University), Sofie Claerhout(KU Leuven), Qing Lai, M. F. Wu, Jian Huang, Amber M. Froehlich(The University of Texas MD Anderson Cancer Center)
Cited by 17
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k